Final results of EFC6663: a multicenter, international, phase 2 study of alvocidib for patients with fludarabine-refractory chronic lymphocytic leukemia.
about
The potential of venetoclax (ABT-199) in chronic lymphocytic leukemiaHigh-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cellsCell cycle proteins as promising targets in cancer therapySmall Molecule Inhibitors in Chronic Lymphocytic Lymphoma and B Cell Non-Hodgkin Lymphoma.Overview of CDK9 as a target in cancer research.Alvocidib (flavopiridol) for the treatment of chronic lymphocytic leukemia.Potential Use of Flavopiridol in Treatment of Chronic Diseases.Targeting of CDK9 with indirubin 3'-monoxime safely and durably reduces HIV viremia in chronically infected humanized mice.Voruciclib, a clinical stage oral CDK9 inhibitor, represses MCL-1 and sensitizes high-risk Diffuse Large B-cell Lymphoma to BCL2 inhibition.Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia with Novel Targeted Agents.Cell cycle regulation and anticancer drug discovery.The cyclin-dependent kinase inhibitor flavopiridol (alvocidib) inhibits metastasis of human osteosarcoma cells.Potent anti-leukemic activity of a specific cyclin-dependent kinase 9 inhibitor in mouse models of chronic lymphocytic leukemia.
P2860
Q28075504-D25F65B9-CC98-4CE5-A772-15D5A5F45017Q37209768-6DEF7FA5-1730-4D4B-A011-65EBB0D3EFE6Q37693690-53809F2A-5851-4089-955A-6ED08CDBE0ACQ38691282-542EDD0D-8C56-4EC9-980E-0AFDB26E38B6Q38696353-DA853699-FF12-468F-9C01-B5E6436AED43Q38783064-B04808D3-3911-4EE2-9E51-1FE6D79549B9Q38988581-19D6D780-FFF7-4A0E-8DB0-F8EC6328CFD8Q40079572-ACBAEC93-4140-4340-8FA9-39A5AB476806Q47130049-B340C7DF-785D-42E8-B244-22BE2C99417FQ47887134-41F49441-C559-4ED2-80C6-19A352F0D926Q49449591-37424657-2C51-466F-84A6-F3EB84CD0C8BQ54977960-EA0A1A7E-8E0F-41E2-AB2B-45B581AB91FDQ55280895-E77A51FA-B4DF-4026-9112-0847F4DB5A40
P2860
Final results of EFC6663: a multicenter, international, phase 2 study of alvocidib for patients with fludarabine-refractory chronic lymphocytic leukemia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Final results of EFC6663: a mu ...... chronic lymphocytic leukemia.
@ast
Final results of EFC6663: a mu ...... chronic lymphocytic leukemia.
@en
type
label
Final results of EFC6663: a mu ...... chronic lymphocytic leukemia.
@ast
Final results of EFC6663: a mu ...... chronic lymphocytic leukemia.
@en
prefLabel
Final results of EFC6663: a mu ...... chronic lymphocytic leukemia.
@ast
Final results of EFC6663: a mu ...... chronic lymphocytic leukemia.
@en
P2093
P2860
P50
P1433
P1476
Final results of EFC6663: a mu ...... chronic lymphocytic leukemia.
@en
P2093
Amy J Johnson
Andreas Bühler
Ann Janssens
Donald W Milligan
Federico Caligaris-Cappio
Janice Gabrilove
Jeanne Devin
Jennifer R Brown
Leslie Andritsos
Mark C Lanasa
P2860
P304
P356
10.1016/J.LEUKRES.2015.02.001
P577
2015-02-07T00:00:00Z